These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 25295426)

  • 1. A review of the use of stimulants and stimulant alternatives in treating bipolar depression and major depressive disorder.
    Corp SA; Gitlin MJ; Altshuler LL
    J Clin Psychiatry; 2014 Sep; 75(9):1010-8. PubMed ID: 25295426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
    Goss AJ; Kaser M; Costafreda SG; Sahakian BJ; Fu CH
    J Clin Psychiatry; 2013 Nov; 74(11):1101-7. PubMed ID: 24330897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of adjunctive stimulants in adult bipolar depression.
    Dell'Osso B; Ketter TA
    Int J Neuropsychopharmacol; 2013 Feb; 16(1):55-68. PubMed ID: 22717304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the roles of stimulants/stimulant-like drugs and dopamine-agonists in the treatment of bipolar depression.
    Dell'Osso B; Ketter TA; Cremaschi L; Spagnolin G; Altamura AC
    Curr Psychiatry Rep; 2013 Aug; 15(8):378. PubMed ID: 23881710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation.
    Carlson PJ; Merlock MC; Suppes T
    Bipolar Disord; 2004 Oct; 6(5):416-20. PubMed ID: 15383134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulants for depression: On the up and up?
    Malhi GS; Byrow Y; Bassett D; Boyce P; Hopwood M; Lyndon W; Mulder R; Porter R; Singh A; Murray G
    Aust N Z J Psychiatry; 2016 Mar; 50(3):203-7. PubMed ID: 26906078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of dopaminergic and stimulant drugs for the treatment of depression.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Feb; 50(2):11-4. PubMed ID: 22263621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine in psychiatric disorders.
    Reid JG; Gitlin MJ; Altshuler LL
    J Clin Psychiatry; 2013 Jul; 74(7):675-84. PubMed ID: 23945444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturalistic long-term use of methylphenidate in bipolar disorder.
    Lydon E; El-Mallakh RS
    J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic agents and stimulants as antidepressant augmentation strategies.
    Nierenberg AA; Dougherty D; Rosenbaum JF
    J Clin Psychiatry; 1998; 59 Suppl 5():60-3; discussion 64. PubMed ID: 9635549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulants for treating bipolar disorder: pro and con.
    Grunze H
    Harv Rev Psychiatry; 2014; 22(6):358-62. PubMed ID: 25377610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modafinil in the treatment of depression].
    Videbech P
    Ugeskr Laeger; 2012 Feb; 174(6):348-51. PubMed ID: 22310006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis.
    McIntyre RS; Lee Y; Zhou AJ; Rosenblat JD; Peters EM; Lam RW; Kennedy SH; Rong C; Jerrell JM
    J Clin Psychopharmacol; 2017 Aug; 37(4):412-418. PubMed ID: 28590365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants.
    Lam JY; Freeman MK; Cates ME
    Ann Pharmacother; 2007 Jun; 41(6):1005-12. PubMed ID: 17519297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression.
    Niemegeers P; Maudens KE; Morrens M; Patteet L; Joos L; Neels H; Sabbe BG
    Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1189-97. PubMed ID: 22803602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of stimulant treatment and of stimulant-associated mania/hypomania in bipolar disorder patients.
    Wingo AP; Ghaemi SN
    Psychopharmacol Bull; 2008; 41(4):37-47. PubMed ID: 19015628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the old psychostimulant drugs have a role in managing treatment-resistant depression?
    Parker G; Brotchie H
    Acta Psychiatr Scand; 2010 Apr; 121(4):308-14. PubMed ID: 19594481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of atypical antipsychotics in refractory depression and anxiety.
    Nemeroff CB
    J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.